Bellicum Pharmaceuticals Inc (BLCM): Baker Bros. Discloses 16% Passive Stake

Among other stocks that Baker Bros. has been bullish on in the last months is Seattle Genetics, Inc. (NASDAQ:SGEN), of which it owns around 28.11 million shares, which represent 22.7% of the company. The fund has been raising its stake in the company for the last several years and has been holding shares since 2004, witnessing the stock gaining more than 400%. Pharmacyclics, Inc. (NASDAQ:PCYC) is the largest position in Baker Bros’ equity portfolfio as of the end of September, and the stock also has had an impressive run over the years, growing by a tenfold over the last ten years.

Disclosure: none